Pharmalot… Pharmalittle… The Weekend Nears

And so, we have officially returned from a speaking engagement in San Diego, although you may have noticed that we worked from the road when possible. Of course, we are back just in time for a blizzard. Oh boy. Nonetheless, being snowed in gives us more time to daydream about weekend plans. Our agenda is obvious – lots of shoveling, hot coffee and naps. But what about you? Some of you may also need to dig your way out, but this is also a chance to tidy up around the mansion, watch a movie or read a book (remember those?). For those of you in nicer climates, well, consider yourselves lucky. Whatever you do this weekend, have a grand time, but be safe. See you soon… FDA Outlines Path To Test Alzheimer’s Drugs Earlier (Reuters) Pfizer Closes Clinical Research Unit In Singapore (Business Times) Vivus And Its Slow Rollout For Its Belviq Diet Pill (Reuters) AstraZeneca Pays $5.5M To Settle Kentucky Medicaid Fraud Suit (WPSD) Medicare Drug Savings Hit $5.7B: HHS (USA Today) J&J Buys Baby Care Products Rival In China (China Post) Viehbacher Sees Sanofi Growth In Diagnostics And Nutrition (Bloomberg News) Appeals Court Upholds Merck’s Vytorin Patent (Reuters) Express Scripts Tries Big Data To Predict Adherence (MedCity News) Teva To Sell California Plant As Part Of Cost Cutting (Dow Jones) Lilly Stops Development Of Rheumatoid Arthritis Drug (Reuters) Amgen Raises Forecast Thanks To Lower Tax Rate (Bloomberg News) EDITOR’S NOTE: Please check this pos...
Source: Pharmalot - Category: Pharma Commentators Authors: Tags: Uncategorized Amgen AstraZeneca Belviq Diet Pills Donut Hole Eli Lilly Express Scripts FDA. Alzheimer's JJ Johnson & Johnson Medicaid Fraud Medicare Merck Pfizer Rheumatoid Arthritis Sanofi Seroquel Teva Pharmaceuticals Source Type: blogs